• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度喀拉拉邦北部地区新冠康复患者的临床表现及其风险因素

Post COVID-19 clinical manifestations and its risk factors among patients in a Northern District in Kerala, India.

作者信息

Raj S V Aswathy, Jacob Abraham, Ambu V, Wilson Tom, Renuka R

机构信息

Department of Community Medicine, Government Medical College Manjeri, Kerala, India.

District Post COVID Clinic and District TB Center, Wayanad, Kerala, India.

出版信息

J Family Med Prim Care. 2022 Sep;11(9):5312-5319. doi: 10.4103/jfmpc.jfmpc_131_22. Epub 2022 Oct 14.

DOI:10.4103/jfmpc.jfmpc_131_22
PMID:36505604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9731023/
Abstract

BACKGROUND

The novel virus SARS-CoV-2 has caused a pandemic of coronavirus disease 2019 (COVID-19). There is emerging evidence of post-COVID-19 manifestations among patients who sustain acute COVID-19. Most studies report fatigue, dyspnea, and myalgia as the common symptoms; however, currently, there is limited knowledge of these post-COVID manifestations and their risk factors, especially in India.

METHODS

A descriptive cross-sectional study was conducted among patients who had attended the district post-COVID clinic, Wayanad district, Kerala, from October 2020 to June 2021. Data were collected by direct/telephonic patient interviews and from their existing case records, using a pretested semi-structured proforma.

RESULTS

The sample size was 667. The mean age of the study population was 45 years (standard deviation [SD]: 14.55). The majority of the population presented with dyspnea (48%), fatigue (32%), and cough (25.6%). Mental health problems were also reported in 6% of participants. The respiratory system was commonly involved (61.2%). Around one-third of the patients (36.4%) had dyspnea on exertion and 11.8% had dyspnea at rest. One-fifth of the population reported aggravation of pre-existing co-morbidity and half of the respondents had persistence of at least one symptom after 6 months. There exist statistically significant associations between identified risk factors, especially gender, increasing age, the severity of COVID-19 infection, history of tobacco/alcohol use, and co-morbidities with outcomes.

CONCLUSION

As post-COVID syndrome is a multisystem disease, integrated rehabilitation is required with targeted intervention for survivors based on their symptoms and needs.

摘要

背景

新型冠状病毒SARS-CoV-2引发了2019冠状病毒病(COVID-19)大流行。在患有急性COVID-19的患者中,出现了COVID-19后表现的新证据。大多数研究报告疲劳、呼吸困难和肌痛是常见症状;然而,目前对于这些COVID后表现及其风险因素的了解有限,尤其是在印度。

方法

对2020年10月至2021年6月期间前往喀拉拉邦韦亚纳德地区区级COVID后诊所就诊的患者进行了一项描述性横断面研究。通过直接/电话患者访谈并从他们现有的病例记录中收集数据,使用预先测试的半结构化表格。

结果

样本量为667。研究人群的平均年龄为45岁(标准差[SD]:14.55)。大多数人表现为呼吸困难(48%)、疲劳(32%)和咳嗽(25.6%)。6%的参与者也报告有心理健康问题。呼吸系统最常受累(61.2%)。约三分之一的患者(36.4%)运动时出现呼吸困难,11.8%的患者静息时出现呼吸困难。五分之一的人报告既往合并症加重,一半的受访者在6个月后仍至少有一种症状持续存在。已确定的风险因素,尤其是性别、年龄增长、COVID-19感染的严重程度、烟草/酒精使用史和合并症与结果之间存在统计学上的显著关联。

结论

由于COVID后综合征是一种多系统疾病,需要对幸存者进行综合康复,并根据他们的症状和需求进行有针对性的干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf8/9731023/14f9be3f8235/JFMPC-11-5312-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf8/9731023/33c2e8707195/JFMPC-11-5312-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf8/9731023/29ea06a28406/JFMPC-11-5312-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf8/9731023/14f9be3f8235/JFMPC-11-5312-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf8/9731023/33c2e8707195/JFMPC-11-5312-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf8/9731023/29ea06a28406/JFMPC-11-5312-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf8/9731023/14f9be3f8235/JFMPC-11-5312-g003.jpg

相似文献

1
Post COVID-19 clinical manifestations and its risk factors among patients in a Northern District in Kerala, India.印度喀拉拉邦北部地区新冠康复患者的临床表现及其风险因素
J Family Med Prim Care. 2022 Sep;11(9):5312-5319. doi: 10.4103/jfmpc.jfmpc_131_22. Epub 2022 Oct 14.
2
Manifestations and risk factors of post COVID syndrome among COVID-19 patients presented with minimal symptoms - A study from Kerala, India.症状轻微的新冠病毒病患者出现新冠后综合征的表现及危险因素——一项来自印度喀拉拉邦的研究
J Family Med Prim Care. 2021 Nov;10(11):4023-4029. doi: 10.4103/jfmpc.jfmpc_851_21. Epub 2021 Nov 29.
3
The COVID-19 Sequelae: A Cross-Sectional Evaluation of Post-recovery Symptoms and the Need for Rehabilitation of COVID-19 Survivors.新冠后遗症:新冠康复者康复后症状的横断面评估及康复需求
Cureus. 2021 Feb 2;13(2):e13080. doi: 10.7759/cureus.13080.
4
Characterization of Post-COVID-19 Clinical Manifestations Among Patients Visiting a Post-COVID-19 Clinic in a Tertiary Care Center: A Descriptive Study.三级医疗中心新冠后诊所就诊患者的新冠后临床表现特征:一项描述性研究
Cureus. 2023 Jul 7;15(7):e41523. doi: 10.7759/cureus.41523. eCollection 2023 Jul.
5
Persisting and New Onset Symptomatology and Determinants of Functional Limitation of Post Acute COVID-19 Syndrome Cases- A Study from a Northern District of Kerala.持续性和新发症状学以及新冠后急性综合征病例功能受限的决定因素——喀拉拉邦北部地区的一项研究
Indian J Community Med. 2023 Mar-Apr;48(2):250-257. doi: 10.4103/ijcm.ijcm_170_22. Epub 2023 Apr 7.
6
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.不同随访期的新冠后综合征症状的流行率:系统评价和荟萃分析。
Clin Microbiol Infect. 2022 May;28(5):657-666. doi: 10.1016/j.cmi.2022.01.014. Epub 2022 Feb 3.
7
Post-COVID-19 Syndrome Clinical Manifestations: A Systematic Review.新冠后综合征的临床表现:一项系统综述。
Antiinflamm Antiallergy Agents Med Chem. 2022;21(2):115-120. doi: 10.2174/1871523021666220328115818.
8
Prevalence and determinants of post-COVID-19 syndrome among patients 6 months post-discharge from a teaching hospital in South India.印度南部一家教学医院出院6个月后的新冠肺炎康复者中新冠后综合征的患病率及影响因素
J Family Med Prim Care. 2024 Apr;13(4):1454-1459. doi: 10.4103/jfmpc.jfmpc_1616_23. Epub 2024 Apr 22.
9
Risk factors for post-acute sequelae of COVID-19 in hospitalized patients: An observational study based on a survey in a tertiary care center in Türkiye.COVID-19 住院患者发生急性后期后遗症的风险因素:基于土耳其一家三级保健中心调查的观察性研究。
Tuberk Toraks. 2023 Sep;71(3):261-272. doi: 10.5578/tt.20239707.
10
Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study.长新冠的临床特征和风险因素:对PoLoCOV研究的STOP-COVID登记处患者的回顾性分析
Viruses. 2022 Aug 11;14(8):1755. doi: 10.3390/v14081755.

引用本文的文献

1
Symptom Trajectories and Clinical Subtypes in Post-COVID-19 Condition: Systematic Review and Clustering Analysis.新冠后状况的症状轨迹与临床亚型:系统评价与聚类分析
JMIR Public Health Surveill. 2025 Jul 18;11:e72221. doi: 10.2196/72221.
2
Unmasking the Long-Term Effects of COVID-19 With a Focus on Chronic Fatigue Syndrome: A Community-Based Study From India.揭示新冠病毒病的长期影响,重点关注慢性疲劳综合征:一项来自印度的社区研究
Cureus. 2025 Mar 14;17(3):e80597. doi: 10.7759/cureus.80597. eCollection 2025 Mar.
3
Global Prevalence of Long COVID, its Subtypes and Risk factors: An Updated Systematic Review and Meta-Analysis.

本文引用的文献

1
Erratum to "Long COVID: An overview" [Diabetes Metabol. Syndr. Clin. Res. Rev. (2021) 869-875].《“长新冠”概述》的勘误 [《糖尿病与代谢综合征:临床研究评论》(2021年)第869 - 875页] 。
Diabetes Metab Syndr. 2022 Dec;16(12):102660. doi: 10.1016/j.dsx.2022.102660. Epub 2022 Nov 7.
2
Long COVID: "And the fire rages on".长期新冠:“火势持续蔓延” 。
Lung India. 2021 Nov-Dec;38(6):564-570. doi: 10.4103/lungindia.lungindia_980_20.
3
Post COVID-19 sequelae: A prospective observational study from Northern India.新冠后遗症:来自印度北部的前瞻性观察研究。
长新冠的全球患病率、亚型及风险因素:一项更新的系统评价与荟萃分析
medRxiv. 2025 Jan 6:2025.01.01.24319384. doi: 10.1101/2025.01.01.24319384.
4
Dermatological complications due to post‑COVID‑19 syndrome: A systematic review.新冠后综合征导致的皮肤并发症:一项系统综述。
Med Int (Lond). 2024 Nov 26;5(1):9. doi: 10.3892/mi.2024.208. eCollection 2025 Jan-Feb.
5
SARS-CoV-2 and the nervous system: current perspectives.SARS-CoV-2 与神经系统:当前的观点。
Arch Virol. 2023 Jun 1;168(6):171. doi: 10.1007/s00705-023-05801-x.
Drug Discov Ther. 2021 Nov 21;15(5):254-260. doi: 10.5582/ddt.2021.01093. Epub 2021 Oct 30.
4
Post-COVID syndrome. A case series and comprehensive review.新冠后综合征。病例系列与综合综述。
Autoimmun Rev. 2021 Nov;20(11):102947. doi: 10.1016/j.autrev.2021.102947. Epub 2021 Sep 10.
5
Post COVID-19 Syndrome ("Long COVID") and Diabetes: Challenges in Diagnosis and Management.新冠后综合征(“长新冠”)与糖尿病:诊断与管理面临的挑战。
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102235. doi: 10.1016/j.dsx.2021.102235. Epub 2021 Jul 28.
6
Post-COVID syndrome: A single-center questionnaire study on 1007 participants recovered from COVID-19.新冠后综合征:一项针对 1007 名 COVID-19 康复患者的单中心问卷调查研究。
J Med Virol. 2021 Dec;93(12):6566-6574. doi: 10.1002/jmv.27198. Epub 2021 Jul 28.
7
Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge.2019冠状病毒病患者出院一年后的长期预后
J Clin Med. 2021 Jun 30;10(13):2945. doi: 10.3390/jcm10132945.
8
Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data.新冠后综合征:疾病病毒感染后阶段的持续症状。当前数据的系统综述
Front Med (Lausanne). 2021 May 4;8:653516. doi: 10.3389/fmed.2021.653516. eCollection 2021.
9
Long COVID: An overview.长新冠:概述。
Diabetes Metab Syndr. 2021 May-Jun;15(3):869-875. doi: 10.1016/j.dsx.2021.04.007. Epub 2021 Apr 20.
10
Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study.新冠后综合征在因新冠住院的个体中的表现:回顾性队列研究。
BMJ. 2021 Mar 31;372:n693. doi: 10.1136/bmj.n693.